{"abnormal behaviour": 6.3, "aggression": 4.69, "agitation": 6.57, "akinesia": 144.6, "aspartate aminotransferase increased": 3.35, "blood alkaline phosphatase increased": 5.14, "blood creatine phosphokinase increased": 8.61, "c-reactive protein increased": 2.71, "chromaturia": 17.08, "coma": 5.9, "confusional state": 4.66, "constipation": 3.33, "dehydration": 3.46, "delirium": 5.58, "delusion": 22.49, "depressed level of consciousness": 3.07, "disorientation": 5.26, "drug interaction": 2.02, "dyskinesia": 45.37, "dysphagia": 16.69, "fall": 4.59, "feeling abnormal": 2.17, "gait disturbance": 3.94, "gait inability": 3.94, "gamma-glutamyltransferase increased": 4.2, "hallucination": 27.93, "hallucination, visual": 31.79, "movement disorder": 3.82, "muscle rigidity": 38.62, "musculoskeletal stiffness": 2.79, "neuroleptic malignant syndrome": 26.08, "parkinson's disease": 145.53, "pneumonia aspiration": 13.75, "product availability issue": 23.37, "product complaint": 16.78, "psychomotor hyperactivity": 13.38, "psychotic disorder": 6.21, "rhabdomyolysis": 9.45, "somnolence": 2.55, "sudden onset of sleep": 100.3, "therapeutic response shortened": 50.89, "tremor": 2.74, "weight decreased": 2.18, "wrong technique in product usage process": 16.92}